Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
骨髓微环境衰老机制及其对克隆造血进展的影响
基本信息
- 批准号:10665803
- 负责人:
- 金额:$ 53.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcute Myelocytic LeukemiaAddressAgingAreaBiological MarkersBiology of AgingBone MarrowBone marrow failureCell AgingCell modelCellsChronicClinicalClonal ExpansionDNA RepairDNMT3aDataDevelopmentDysmyelopoietic SyndromesElderlyEpigenetic ProcessEventFailureFunctional disorderGene FrequencyGenesGenomeHIVHematopoiesisHematopoieticHematopoietic stem cellsHeterogeneityHomeostasisHumanIndividualInfectionInflammationInflammatoryInterleukin-1 betaInterventionKnowledgeLesionLongevityMacrophageMalignant NeoplasmsMarrowMissionModelingMolecularMorbidity - disease rateMusMutateMutationMyeloproliferative diseaseNatural ImmunityNucleotidesOrganismOxidoreductasePathologyPathway interactionsPatientsPersonsPharmaceutical PreparationsPhenotypePlayPopulationPreleukemiaProcessPublic HealthRNARecording of previous eventsRegulationReportingRepressionResearchResolutionRetrotranspositionRetrotransposonReverse Transcriptase InhibitorsReverse TranscriptionRiskRoleSirtuinsStromal CellsTestingTimeTranslationsTransplantationUnited States National Institutes of HealthWild Type MouseWorkage relatedagedbone agingcardiovascular risk factorclinical developmentdefined contributionderepressiondisabilityepigenomeexperimental studygenetic elementgenetic varianthematopoietic stem cell fatehigh riskimprovedinterestleukemialoss of functionmiddle agemortalitymutantnoveloverexpressionpreventprogression riskrisk predictionsenescencesex
项目摘要
Project Abstract
Mutated clones in hematopoietic cells, also known as clonal hematopoiesis (CH) are present in healthy
individuals and expand with aging. In spite of normal hematopoietic parameters, individuals with CH have
increased risk of myeloid neoplasms, cardiovascular risk and all-cause mortality. We recently showed that the
aged microenvironment contributes to hematopoietic stem cell fate choices. While the presence of clonal
hematopoiesis in healthy individuals has been widely reported, and its expansion with aging is established,
whether the aging microenvironment modifies clonal dynamics and contributes to clonal selection leading to
progression to myelodysplastic syndromes (MDS) remains unexplored. Sirtuin6/SIRT6 is a regulator of genome
and epigenome stability. SIRT6 is responsible for more efficient DNA repair in long-lived species. Moreover
SIRT6 plays a critical role in suppressing retrotransposon expression, demonstrating that retrotransposon activity
directly contributes to the progeroid phenotype in mice lacking SIRT6, in part through activation of innate
immunity. Nucleotide reverse transcriptase inhibitors (NRTIs) developed as HIV drugs, inhibit retrotransposition,
reduce inflammation, improve aging biomarkers in wild type mice, and extend the lifespan of progeroid mice
lacking SIRT6. We hypothesize that aging-associated de-repression of retrotransposons promotes pro-
inflammatory changes of specific hematopoietic stem cell-supportive niche populations (marrow macrophages
and multipotent stromal cells) which drive clonal progression to myeloid neoplasms. To test this hypothesis,
using relevant models of clonal hematopoiesis we will examine whether 1) pre-leukemic mutations form clones
and progress to MDS more readily in the aged microenvironment by transplanting them into young versus aged
recipient mice; 2) SIRT6 overexpression in key microenvironmental populations slows the rate of
microenvironmental and hematopoietic aging, clonal expansion and progression to MDS; 3) repressing LINE1
retrotranspositions with inhibitors of reverse transcriptases (NRTIs) slows clonal expansion and provides a
mechanism to discover novel microenvironmental regulators of clonal hematopoiesis progression.
项目摘要
造血细胞中的突变克隆,也称为克隆性造血(CH),在健康人群中存在
并随着年龄的增长而扩大。尽管有正常的造血参数,但慢性肝炎患者
增加患髓系肿瘤的风险、心血管风险和全因死亡率。我们最近展示了
衰老的微环境有助于造血干细胞的命运选择。而克隆人的存在
健康个体的造血功能已经被广泛报道,而且随着年龄的增长,它的扩张性也得到了证实,
衰老的微环境是否改变克隆动力学并有助于克隆选择导致
进展为骨髓增生异常综合征(MDS)仍未被探索。Sirtuin6/SIRT6是基因组的调节因子
和表观基因组稳定性。在长寿物种中,SIRT6负责更有效的DNA修复。更有甚者
SIRT6在抑制反转录转座子的表达中起关键作用,表明反转录转座子的活性
在缺乏SIRT6的小鼠中,直接对孕激素表型有贡献,部分是通过激活先天
豁免权。作为HIV药物开发的核苷酸逆转录酶抑制剂(NRTI),抑制逆转座子,
减轻炎症,改善野生型小鼠衰老生物标志物,延长孕期小鼠寿命
缺少SIRT6。我们假设与衰老相关的反转录转座子的去抑制促进了前转座子的表达。
特定的造血干细胞支持生态位群体(骨髓巨噬细胞)的炎性变化
和多能基质细胞),推动向髓系肿瘤的克隆性进展。为了检验这一假设,
利用克隆性造血的相关模型,我们将检查1)白血病前期突变是否形成克隆
通过将MDS移植到年轻人而不是老年人,更容易在老年微环境中进展为MDS
受体小鼠;2)SIRT6在关键微环境人群中的过度表达减缓了
微环境和造血老化、克隆性扩张和进展为MDS;3)抑制LINE1
逆转录酶抑制剂(NRTI)的逆转座可减缓克隆扩张,并提供
发现克隆性造血进展的新的微环境调节机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura M Calvi其他文献
Laura M Calvi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura M Calvi', 18)}}的其他基金
Efferocytosis by Bone Marrow Stromal Cells and Bone Aging
骨髓基质细胞的胞吞作用和骨老化
- 批准号:
10629389 - 财政年份:2022
- 资助金额:
$ 53.49万 - 项目类别:
Efferocytosis by Bone Marrow Stromal Cells and Bone Aging
骨髓基质细胞的胞吞作用和骨老化
- 批准号:
10430637 - 财政年份:2022
- 资助金额:
$ 53.49万 - 项目类别:
PGE2 mitigation of acute and late radiation injury
PGE2 缓解急性和晚期放射损伤
- 批准号:
9540462 - 财政年份:2017
- 资助金额:
$ 53.49万 - 项目类别:
PGE2 mitigation of acute and late radiation injury
PGE2 缓解急性和晚期放射损伤
- 批准号:
8572275 - 财政年份:2013
- 资助金额:
$ 53.49万 - 项目类别:
PGE2 mitigation of acute and late radiation injury
PGE2 缓解急性和晚期辐射损伤
- 批准号:
8660638 - 财政年份:2013
- 资助金额:
$ 53.49万 - 项目类别:
PGE2 mitigation of acute and late radiation injury
PGE2 缓解急性和晚期辐射损伤
- 批准号:
8840882 - 财政年份:2013
- 资助金额:
$ 53.49万 - 项目类别:
相似海外基金
Computing analysis of leukemic stem cell dynamics in acute myelocytic leukemia
急性粒细胞白血病白血病干细胞动力学的计算分析
- 批准号:
19K08356 - 财政年份:2019
- 资助金额:
$ 53.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of immunotoxins with super-targeting mAb in the acute myelocytic leukemia
在急性髓细胞白血病中使用超靶向单克隆抗体产生免疫毒素
- 批准号:
23501309 - 财政年份:2011
- 资助金额:
$ 53.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
- 批准号:
3556971 - 财政年份:1980
- 资助金额:
$ 53.49万 - 项目类别:
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
- 批准号:
3556968 - 财政年份:1980
- 资助金额:
$ 53.49万 - 项目类别:
ERADICATION OF ACUTE MYELOCYTIC LEUKEMIA CELLS BY MAB THERAPY
通过 MAB 疗法根除急性粒细胞白血病细胞
- 批准号:
3889304 - 财政年份:
- 资助金额:
$ 53.49万 - 项目类别: